Showing results (1-10 of 371) with videos related to
Sort By:
Pageof 38
ESMO Real World Data and Digital Oncology|February 6, 2026
Core variables for real-world clinicogenomic data collection in precision oncologyR Dienstmann, A Hackshaw, J-Y Blay, et al.ESMO Open|March 6, 2021
Intrapatient comparisons of efficacy in a single-arm trial of entrectinib in tumour-agnostic indicationsM G Krebs, J-Y Blay, C Le Tourneau, et al.Bulletin Du Cancer|December 8, 2010
[Molecularly targeted therapy in head and neck cancer]C Le TourneauCancer Treatment Reviews|November 7, 2007
New developments in multitargeted therapy for patients with solid tumoursC Le Tourneau, S Faivre, E RaymondCurrent Pharmaceutical Design|November 30, 2007
Aplidine: a paradigm of how to handle the activity and toxicity of a novel marine anticancer poisonC Le Tourneau, E Raymond, S FaivreAnnals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2015
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trialsX Paoletti, M Ezzalfani, C Le TourneauAnnals of Oncology : Official Journal of the European Society for Medical Oncology|July 2, 2010
Updating progress in sarcoma therapy with mTOR inhibitorsJ-Y BlayAnnals of Oncology : Official Journal of the European Society for Medical Oncology|May 12, 2009
New paradigms in gastrointestinal stromal tumour managementJ-Y BlayAnnals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2009
Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinibJ-Y BlayBulletin Du Cancer|January 22, 1998
[Primary cerebral non-Hodgkin lymphoma in non-immunocompromised subjects]J Y BlayPageof 38